Table II

Characteristics of the training and the test sets

BMI, body mass index. Values in parentheses are interquartile range.

Training setTest set
CADaControlsaRamipril samplesHannover samplesCADaControlsa
Total number of patients3020182324712
Sex, male/female22/814/614/4101/13734/137/5
Age (yr)62 ± 1154 ± 1359 ± 1134 ± 1161 ± 1254 ± 12
BMI (kg/m2)25.9 ± 3.825.7 ± 3.530.5 ± 5.026.5 ± 5.324.8 ± 2.2
Smoker, yes/no5/252/184/148/391/11
Diabetic, n101850
Systolic blood pressure (mm Hg)133 ± 19123 ± 11151 ± 13132 ± 20124 ± 13
Diastolic blood pressure (mm Hg)75 ± 1176 ± 786 ± 1076 ± 875 ± 8
Total cholesterol (mmol/liter)3.9 ± 0.85.2 ± 1.05.5 ± 1.33.9 ± 0.95.6 ± 0.6
LDL cholesterol (mmol/liter)1.9 ± 0.63.0 ± 0.83.4 ± 1.01.9 ± 0.83.4 ± 0.6
HDL cholesterol (mmol/liter)1.2 ± 0.31.4 ± 0.41.3 ± 0.31.2 ± 0.31.6 ± 0.4
Triglycerides (mmol/liter)1.6 (1.2; 2.4)1.3 (1.1; 2.5)1.6 (1.0; 2.7)1.4 (1.2; 1.9)1.3 (1.0; 1.6)
  • a In all depicted parameters there were no differences between CAD patients and controls in the training set and test set, respectively.